Stock Events

Amphastar Pharmaceuticals (29A.F) Q4 2023 Earnings

28FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
0.81
0.82
0.83
0.84

Details

Expected EPS
0.839206056
Actual EPS
0.8118968000000001
Surprise EPS
-0.03
Surprise Percent
+3.25%

Description

Amphastar Pharmaceuticals (29A.F) has reported earnings of 0.8118968000000001 per share for Q4 2023.

0 Comments

Share your thoughts